Abstract
Aim: To evaluate the behavior of oral keratinocytes in the presence of Vitamin C (Vit C) and its anti-inflammatory potential. Materials & methods: Oral keratinocytes were initially exposed to 0.1–2.5 mM of Vit C and the metabolic activity and cell migration were evaluated using MTS assay and Ibidi culture inserts, respectively. After, the cells were challenged with Candida albicans and inflammatory markers were analyzed by qPCR. Results: The treatment was not cytotoxic, and the highest concentrations increased the metabolic activity at 24 h. Vit C delayed the cell migration at 48 and 72 h. Interestingly, it downregulated the genes IL-8 and IL-1β. Conclusion: Vit C could be an interesting adjuvant to anti-fungal treatment due to its anti-inflammatory potential.
Plain language summary
Vitamin C, also known as ascorbic acid, is a vitamin commonly found in fruits and vegetables. It is popular for supporting our immune system, so is commonly taken as a supplement. We looked at the action of vitamin C on cells from the mouth and its potential to reduce inflammation in a fungal disease of the mouth – oral candidiasis. We showed that vitamin C is not toxic to cells of the mouth and may reduce inflammation in cells infected by the fungus. This suggests that vitamin C could be used as a complementary therapy for oral candidiasis.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Oral candidiasis: a disease of opportunity. J. Fungi. 6(1), 1–28 (2020). • Interesting review about oral candidiasis.
- 2. . Oral candidiasis: an overview. J. Oral Maxillofac. Pathol. 18(Suppl. 1), S81–S85 (2014).
- 3. . Diagnosis and management of oral candidosis. Br. Dent. J. 223(9), 675–681 (2017).
- 4. . Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal. Microorganisms 8(2), 154 (2020).
- 5. . Antifungals discovery: an insight into new strategies to combat antifungal resistance. Lett. Appl. Microbiol. 66(1), 2–13 (2018).
- 6. . Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. J. Clin. Aesthet. Dermatol. 10(7), 14–17 (2017).
- 7. . Ascorbic acid inhibition of candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2. Eukaryot Cell 13(10), 1278–1289 (2014). •• This study investigated Vitamin C mechanisms of action on Candida albicans strains.
- 8. . Ascorbic acid modulates pathogenecity markers of Candida albicans. Int. J. Microbiol. Res. 1(1), 19–24 (2009). •• Interesting manuscript about Vitamin C modulatory effects on Candida albicans strains.
- 9. . Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism. Future Microbiol. 11(12), 1535–1547 (2016). •• Indicated that ascorbate may present antimicrobial effects against Candida albicans strains.
- 10. . Ascorbic acid suppresses house dust mite-induced expression of interleukin-8 in human respiratory epithelial cells. J. Cancer Prev. 26(1), 64–70 (2021). •• Demonstrated in a different model of infection that vitamin C may present an anti-inflammatory effect.
- 11. . Evaluation of the anti-inflammatory effect of locally delivered vitamin C in the treatment of persistent gingival inflammation: clinical and histopathological study. J. Nutr. Metab. 2016, 2978741 (2016).
- 12. . Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials. Sci. Rep. 11, 6628 (2021).
- 13. . Effect of the pH on the antibacterial potential and cytotoxicity of different plasma-activated liquids. Int. J. Mol. Sci. 23(22), 13893 (2022).
- 14. . An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLOS ONE 15(7), e0232565 (2020).
- 15. . Role of antifungal combinations in difficult to treat candida infections. J. Fungi. 7(9), 731 (2021).
- 16. . High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J. Exp. Clin. Cancer Res. 40(1), 343 (2021).
- 17. . Vitamin C modes of action in calcium-involved signaling in the brain. Antioxidants 12(2), 231 (2023).
- 18. . Immune modulatory and antioxidant effects of locally administrated vitamin C in experimental periodontitis in rats. Acta Odontol. Scand. 78(6), 425–432 (2020).
- 19. . Oral candidosis: pathophysiology and best practice for diagnosis, classification, and successful management. J. Fungi 7(7), 555 (2021).
- 20. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399(6731), 70–75 (1999).
- 21. . Biomolecular and cellular effects in skin wound healing: the association between ascorbic acid and hypoxia-induced factor. J. Biol. Eng. 17(1), 62 (2023).
- 22. Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression. Sci. Rep. 8(1), 11372 (2018).
- 23. . Isolation of epidermal keratinocytes from human skin: the scratch-wound assay for assessment of epidermal keratinocyte migration. Methods Mol. Biol. 2154, 1–12 (2020).
- 24. . In-vitro and in-vivo evaluations of tocotrienol-rich nanoemulsified system on skin wound healing. PLOS ONE 17(5), e0267381 (2022).
- 25. . Rinsing with L-ascorbic acid exhibits concentration-dependent effects on human gingival fibroblast in vitro wound healing behavior. Int. J. Dent. 2020, 4706418 (2020).
- 26. Ascorbic acid 2-glucoside preconditioning enhances the ability of bone marrow mesenchymal stem cells in promoting wound healing. Stem Cell Res. Ther. 13(1), 119 (2022).
- 27. . Characterization of keratinocyte differentiation induced by ascorbic acid: protein kinase C involvement and vitamin C. J. Invest. Dermatol. 118(2), 372–379 (2002).
- 28. . In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection. Int. J. Med. Microbiol. 296(4–5), 301–311 (2006).
- 29. . Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol. Immunol. 18(3), 165–170 (2003).
- 30. . Role for IL-1 family cytokines in fungal infections. Front Microbiol. 12, 633047 (2021).
- 31. Different host immunological response to C. albicans by human oral and vaginal epithelial cells. Mycopathologia 184(1), 1–12 (2019).
- 32. Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J. Invest. Dermatol. 127(3), 698–706 (2007).
- 33. . Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol. 165(12), 7180–7188 (2000).
- 34. . Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants 11(10), 1993 (2022).
- 35. The effects of vitamin C on respiratory, allergic and immunological diseases: an experimental and clinical-based review. Inflammopharmacology 31(2), 653–672 (2023).
- 36. . Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood 99(9), 3205–3212 (2002).
- 37. Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages. Mediators Inflamm. 2014, 426740 (2014). •• In this study, a different model of infection was performed, in which vitamin C showed anti-inflammatory effect.
- 38. Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14. PLOS ONE 12(12), e0189939 (2017).
- 39. . Pathogenesis and virulence of Candida albicans. Virulence 13(1), 89–121 (2022).